1. Home
  2. LQDA vs PLMR Comparison

LQDA vs PLMR Comparison

Compare LQDA & PLMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$42.70

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Palomar Holdings Inc.

PLMR

Palomar Holdings Inc.

HOLD

Current Price

$126.59

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
PLMR
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
LQDA
PLMR
Price
$42.70
$126.59
Analyst Decision
Strong Buy
Buy
Analyst Count
10
8
Target Price
$38.60
$156.29
AVG Volume (30 Days)
2.3M
206.3K
Earning Date
03-18-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.73
EPS
N/A
6.40
Revenue
$69,216,000.00
$778,362,000.00
Revenue This Year
$993.31
$270.49
Revenue Next Year
$219.14
$20.27
P/E Ratio
N/A
$19.93
Revenue Growth
343.41
54.59
52 Week Low
$11.26
$107.75
52 Week High
$46.67
$175.85

Technical Indicators

Market Signals
Indicator
LQDA
PLMR
Relative Strength Index (RSI) 59.86 55.06
Support Level $41.34 $118.44
Resistance Level $46.67 $131.18
Average True Range (ATR) 2.51 4.59
MACD -0.02 0.26
Stochastic Oscillator 63.78 84.57

Price Performance

Historical Comparison
LQDA
PLMR

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About PLMR Palomar Holdings Inc.

Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.

Share on Social Networks: